XAIR – Beyond Air Inc

Float Short %

6.83

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.98

EPS Last/This Y

10.5

EPS This/Next Y

1.95

Price

1.15

Target Price

10.33

Analyst Recom

1.5

Performance Q

-65.26

Relative Volume

0.05

Beta

0.3

Ticker: XAIR

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	XAIR	1.75	N/A	N/A	0
2025-11-11	XAIR	1.46	N/A	N/A	0
2025-11-12	XAIR	1.47	N/A	N/A	0
2025-11-13	XAIR	1.43	N/A	N/A	0
2025-11-14	XAIR	1.37	N/A	N/A	0
2025-11-17	XAIR	1.35	N/A	N/A	0
2025-11-18	XAIR	1.36	N/A	N/A	0
2025-11-19	XAIR	1.37	N/A	N/A	0
2025-11-20	XAIR	1.21	N/A	N/A	0
2025-11-21	XAIR	1.33	N/A	N/A	0
2025-11-24	XAIR	1.291	N/A	N/A	0
2025-11-25	XAIR	1.34	N/A	N/A	0
2025-11-26	XAIR	1.33	N/A	N/A	0
2025-12-01	XAIR	1.193	0.00	0.00	3659
2025-12-02	XAIR	1.15	0.00	0.00	3659
2025-12-03	XAIR	1.11	0.00	0.00	3659
2025-12-04	XAIR	1.29	0.00	999.99	3669
2025-12-05	XAIR	1.15	0.00	999.99	3669
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	XAIR	1.74	-	-	-2.25
2025-11-11	XAIR	1.46	-	-	-2.25
2025-11-12	XAIR	1.46	-	-	-2.25
2025-11-13	XAIR	1.42	-	-	-2.25
2025-11-14	XAIR	1.38	-	-	-2.25
2025-11-17	XAIR	1.34	-	-	-3.30
2025-11-18	XAIR	1.37	-	-	-3.30
2025-11-19	XAIR	1.35	-	-	-3.30
2025-11-20	XAIR	1.21	-	-	-3.30
2025-11-21	XAIR	1.32	-	-	-3.30
2025-11-24	XAIR	1.29	-	-	-3.30
2025-11-25	XAIR	1.34	-	-	-3.30
2025-11-26	XAIR	1.34	-	-	-3.30
2025-12-01	XAIR	1.19	-	-	-3.30
2025-12-02	XAIR	1.14	-	-	-3.30
2025-12-03	XAIR	1.09	-	-	-3.30
2025-12-04	XAIR	1.28	-	-	-3.30
2025-12-05	XAIR	1.15	-	-	-3.30
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	XAIR	1.32	-8.63	2.12
2025-11-11	XAIR	1.32	-8.63	2.12
2025-11-12	XAIR	1.31	-8.63	1.63
2025-11-13	XAIR	1.31	-8.63	1.61
2025-11-14	XAIR	1.31	-8.63	1.61
2025-11-17	XAIR	1.31	0.84	1.61
2025-11-18	XAIR	1.30	0.84	1.61
2025-11-19	XAIR	1.30	0.84	1.61
2025-11-20	XAIR	1.30	0.84	1.61
2025-11-21	XAIR	1.30	0.84	1.61
2025-11-24	XAIR	1.30	2.47	1.61
2025-11-25	XAIR	1.31	2.47	1.61
2025-11-26	XAIR	1.31	2.47	6.83
2025-12-01	XAIR	1.31	2.47	6.83
2025-12-02	XAIR	1.31	2.47	6.83
2025-12-03	XAIR	1.31	2.47	6.83
2025-12-04	XAIR	1.31	2.47	6.83
2025-12-05	XAIR	1.31	2.47	6.83
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-1.25

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

-0.27

Insider Transactions

1.31

Institutional Transactions

2.47

Beta

0.3

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.7

Max Drawdown 5-Year %

-99.7

Target Price

10.33

P/E

Forward P/E

PEG

P/S

1.59

P/B

0.72

P/Free Cash Flow

EPS

-7.53

Average EPS Est. Cur. Y

-3.3

EPS Next Y. (Est.)

-1.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-632.51

Relative Volume

0.05

Return on Equity vs Sector %

-315.1

Return on Equity vs Industry %

-306

EPS 1 7Days Diff

-1

EPS 1 30Days Diff

-1.05

EBIT Estimation

Beyond Air, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 61

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

stock quote shares XAIR – Beyond Air Inc Stock Price stock today

news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch XAIR – Beyond Air Inc yahoo finance google finance

stock history XAIR – Beyond Air Inc invest stock market

stock prices XAIR premarket after hours

ticker XAIR fair value insiders trading

OPGN – Opgen Inc

Float Short %

1.02

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

-57.39

Relative Volume

Beta

-0.64

Ticker: OPGN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	OPGN	5.03	N/A	N/A	0
2025-11-11	OPGN	4.95	N/A	N/A	0
2025-11-12	OPGN	4.95	N/A	N/A	0
2025-11-13	OPGN	5	N/A	N/A	0
2025-11-14	OPGN	4.06	N/A	N/A	0
2025-11-17	OPGN	5.01	N/A	N/A	0
2025-11-18	OPGN	5.04	N/A	N/A	0
2025-11-19	OPGN	5.04	N/A	N/A	0
2025-11-20	OPGN	5	N/A	N/A	0
2025-11-21	OPGN	4.95	N/A	N/A	0
2025-11-24	OPGN	5.71	N/A	N/A	0
2025-11-25	OPGN	5.7	N/A	N/A	0
2025-11-26	OPGN	6.4	N/A	N/A	0
2025-12-01	OPGN	8.5	N/A	N/A	0
2025-12-02	OPGN	9	N/A	N/A	0
2025-12-03	OPGN	9.11	N/A	N/A	0
2025-12-04	OPGN	10	N/A	N/A	0
2025-12-05	OPGN	10.5	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	OPGN	5.03	-	-	-
2025-11-11	OPGN	5.02	-	-	-
2025-11-12	OPGN	4.00	-	-	-
2025-11-13	OPGN	5.00	-	-	-
2025-11-14	OPGN	5.00	-	-	-
2025-11-17	OPGN	5.01	-	-	-
2025-11-18	OPGN	4.02	-	-	-
2025-11-19	OPGN	3.25	-	-	-
2025-11-20	OPGN	3.25	-	-	-
2025-11-21	OPGN	4.85	-	-	-
2025-11-24	OPGN	5.75	-	-	-
2025-11-25	OPGN	5.70	-	-	-
2025-11-26	OPGN	6.40	-	-	-
2025-12-01	OPGN	7.28	-	-	-
2025-12-02	OPGN	9.00	-	-	-
2025-12-03	OPGN	10.55	-	-	-
2025-12-04	OPGN	9.00	-	-	-
2025-12-05	OPGN	10.00	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

-0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

6.13

P/B

P/Free Cash Flow

EPS

-40.32

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

39.1

Return on Equity vs Industry %

48.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

OpGen, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 1

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.

stock quote shares OPGN – Opgen Inc Stock Price stock today

news today OPGN – Opgen Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch OPGN – Opgen Inc yahoo finance google finance

stock history OPGN – Opgen Inc invest stock market

stock prices OPGN premarket after hours

ticker OPGN fair value insiders trading

OFIX – Orthofix Medical Inc

Float Short %

3.87

Margin Of Safety %

Put/Call OI Ratio

8.89

EPS Next Q Diff

0.43

EPS Last/This Y

3.99

EPS This/Next Y

-0.27

Price

15.9

Target Price

21.33

Analyst Recom

1.5

Performance Q

8.16

Relative Volume

0.65

Beta

0.79

Ticker: OFIX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	OFIX	15.04	7.79	0.00	1459
2025-11-11	OFIX	15.39	7.61	16.00	1463
2025-11-12	OFIX	15.31	7.61	16.00	1463
2025-11-13	OFIX	15.03	7.47	0.00	1449
2025-11-14	OFIX	14.95	7.47	0.00	1449
2025-11-17	OFIX	14.4	7.47	0.00	1449
2025-11-18	OFIX	14.41	7.47	0.00	1449
2025-11-19	OFIX	14.48	7.43	999.99	1450
2025-11-20	OFIX	14.29	7.43	999.99	1450
2025-11-21	OFIX	15.26	7.43	999.99	1450
2025-11-24	OFIX	15.82	7.43	999.99	1450
2025-11-25	OFIX	16.16	8.88	1.00	1205
2025-11-26	OFIX	16.12	8.88	1.00	1205
2025-12-01	OFIX	15.87	8.89	0.00	1206
2025-12-02	OFIX	15.73	8.89	0.00	1206
2025-12-03	OFIX	15.91	8.89	0.00	1206
2025-12-04	OFIX	15.9	8.89	0.00	1206
2025-12-05	OFIX	15.91	8.89	0.00	1206
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	OFIX	15.03	2372.4	-	0.54
2025-11-11	OFIX	15.38	2372.4	-	0.54
2025-11-12	OFIX	15.31	2372.4	-	0.54
2025-11-13	OFIX	15.02	2372.4	-	0.54
2025-11-14	OFIX	14.95	2762.7	-	0.69
2025-11-17	OFIX	14.40	2762.7	-	0.69
2025-11-18	OFIX	14.42	2762.7	-	0.69
2025-11-19	OFIX	14.46	2762.7	-	0.69
2025-11-20	OFIX	14.28	2762.7	-	0.69
2025-11-21	OFIX	15.29	2762.7	-	0.69
2025-11-24	OFIX	15.80	2762.7	-	0.69
2025-11-25	OFIX	16.13	2762.7	-	0.69
2025-11-26	OFIX	16.12	2762.7	-	0.69
2025-12-01	OFIX	15.86	2762.7	-	0.69
2025-12-02	OFIX	15.72	2762.7	-	0.69
2025-12-03	OFIX	15.92	2762.7	-	0.69
2025-12-04	OFIX	15.90	2762.7	-	0.69
2025-12-05	OFIX	15.90	2762.7	-	0.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	OFIX	1.29	7.85	4.21
2025-11-11	OFIX	1.29	7.85	4.21
2025-11-12	OFIX	1.29	7.85	4.01
2025-11-13	OFIX	-0.49	7.85	4.01
2025-11-14	OFIX	-0.49	7.85	4.01
2025-11-17	OFIX	-0.49	12.19	4.01
2025-11-18	OFIX	-0.48	12.19	4.01
2025-11-19	OFIX	-0.49	12.19	4.01
2025-11-20	OFIX	-0.49	12.19	4.01
2025-11-21	OFIX	-0.49	12.19	4.01
2025-11-24	OFIX	-0.49	-0.97	4.01
2025-11-25	OFIX	-0.49	-0.97	4.01
2025-11-26	OFIX	-0.49	-0.97	3.87
2025-12-01	OFIX	-0.49	-1.15	3.87
2025-12-02	OFIX	-0.49	-1.15	3.87
2025-12-03	OFIX	-0.49	-1.15	3.87
2025-12-04	OFIX	-0.49	-1.15	3.87
2025-12-05	OFIX	-0.49	-1.15	3.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.57

Avg. EPS Est. Current Quarter

0.44

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

-0.49

Institutional Transactions

-1.15

Beta

0.79

Average Sales Estimate Current Quarter

218

Average Sales Estimate Next Quarter

199

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

67.2

Max Drawdown 5-Year %

-79.8

Target Price

21.33

P/E

Forward P/E

PEG

P/S

0.77

P/B

1.42

P/Free Cash Flow

EPS

-3.04

Average EPS Est. Cur. Y

0.69

EPS Next Y. (Est.)

0.42

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.56

Relative Volume

0.65

Return on Equity vs Sector %

-53.8

Return on Equity vs Industry %

-44.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.15

EBIT Estimation

Orthofix Medical Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 1616

Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

stock quote shares OFIX – Orthofix Medical Inc Stock Price stock today

news today OFIX – Orthofix Medical Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch OFIX – Orthofix Medical Inc yahoo finance google finance

stock history OFIX – Orthofix Medical Inc invest stock market

stock prices OFIX premarket after hours

ticker OFIX fair value insiders trading

MDT – Medtronic Plc

Float Short %

1.06

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

0.33

EPS Last/This Y

0.16

EPS This/Next Y

0.46

Price

101.36

Target Price

111.12

Analyst Recom

2.15

Performance Q

Relative Volume

0.72

Beta

0.72

Ticker: MDT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	MDT	92.66	0.41	0.37	239175
2025-11-11	MDT	95.39	0.41	0.09	240189
2025-11-12	MDT	95.83	0.45	0.20	226351
2025-11-13	MDT	96.15	0.45	0.34	228449
2025-11-14	MDT	95.88	0.45	0.24	230195
2025-11-17	MDT	96.35	0.42	1.37	218002
2025-11-18	MDT	100.82	0.47	0.36	234385
2025-11-19	MDT	100.31	0.49	0.60	245841
2025-11-20	MDT	99.36	0.49	0.90	248415
2025-11-21	MDT	101.23	0.49	0.14	253304
2025-11-24	MDT	103.21	0.54	0.42	179900
2025-11-25	MDT	105.36	0.54	0.61	189992
2025-11-26	MDT	105.01	0.57	0.48	202954
2025-12-01	MDT	103.36	0.55	1.01	197325
2025-12-02	MDT	102.04	0.57	0.60	209235
2025-12-03	MDT	101.99	0.58	0.24	212240
2025-12-04	MDT	102.02	0.56	0.29	219908
2025-12-05	MDT	101.35	0.55	0.50	222921
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	MDT	92.66	4.3	892.0	5.62
2025-11-11	MDT	95.40	4.3	1044.3	5.62
2025-11-12	MDT	95.82	4.3	888.5	5.62
2025-11-13	MDT	96.12	4.3	881.6	5.62
2025-11-14	MDT	95.86	4.3	843.3	5.62
2025-11-17	MDT	96.36	4.3	892.9	5.62
2025-11-18	MDT	100.80	4.3	1153.5	5.62
2025-11-19	MDT	100.34	4.3	832.7	5.62
2025-11-20	MDT	99.36	-4.0	799.6	5.64
2025-11-21	MDT	101.20	-4.0	977.6	5.64
2025-11-24	MDT	103.23	-3.8	1014.9	5.64
2025-11-25	MDT	105.35	-3.8	1020.1	5.64
2025-11-26	MDT	105.02	-3.8	855.5	5.64
2025-12-01	MDT	103.38	-3.8	762.7	5.64
2025-12-02	MDT	102.03	-3.8	799.7	5.64
2025-12-03	MDT	101.97	-3.8	875.9	5.64
2025-12-04	MDT	102.02	-3.8	882.7	5.64
2025-12-05	MDT	101.36	-3.8	840.8	5.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	MDT	-0.35	-0.40	1.17
2025-11-11	MDT	-0.35	-0.40	1.17
2025-11-12	MDT	-0.35	-0.40	1.13
2025-11-13	MDT	-0.35	-0.40	1.13
2025-11-14	MDT	-0.35	-0.40	1.13
2025-11-17	MDT	-0.35	1.15	1.13
2025-11-18	MDT	-0.31	1.15	1.13
2025-11-19	MDT	-0.31	1.15	1.13
2025-11-20	MDT	-0.35	1.15	1.13
2025-11-21	MDT	-3.17	1.15	1.13
2025-11-24	MDT	-3.17	0.36	1.13
2025-11-25	MDT	-3.61	0.36	1.13
2025-11-26	MDT	-3.61	0.36	1.06
2025-12-01	MDT	-3.61	0.07	1.06
2025-12-02	MDT	-3.61	0.07	1.06
2025-12-03	MDT	-3.61	0.07	1.06
2025-12-04	MDT	-3.61	0.07	1.06
2025-12-05	MDT	-3.61	0.07	1.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.36

Avg. EPS Est. Current Quarter

1.34

Avg. EPS Est. Next Quarter

1.69

Insider Transactions

-3.61

Institutional Transactions

0.07

Beta

0.72

Average Sales Estimate Current Quarter

8891

Average Sales Estimate Next Quarter

9631

Fair Value

103.35

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.4

Max Drawdown 5-Year %

-45.1

Target Price

111.12

P/E

27.38

Forward P/E

16.57

PEG

4.5

P/S

3.74

P/B

2.67

P/Free Cash Flow

24.96

EPS

3.7

Average EPS Est. Cur. Y

5.65

EPS Next Y. (Est.)

6.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.71

Relative Volume

0.72

Return on Equity vs Sector %

-17.1

Return on Equity vs Industry %

-8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

840.8

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

IRMD – Iradimed Corp

Float Short %

3.33

Margin Of Safety %

-29

Put/Call OI Ratio

0.79

EPS Next Q Diff

0.03

EPS Last/This Y

0.35

EPS This/Next Y

0.25

Price

94.57

Target Price

Analyst Recom

Performance Q

31.62

Relative Volume

0.69

Beta

1.09

Ticker: IRMD

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	IRMD	86.08	0.89	0.00	867
2025-11-11	IRMD	84.6	0.89	0.00	871
2025-11-12	IRMD	86.41	0.96	0.00	835
2025-11-13	IRMD	84.48	0.96	0.00	835
2025-11-14	IRMD	84.56	0.96	1.00	837
2025-11-17	IRMD	85.41	0.97	0.29	836
2025-11-18	IRMD	86.26	0.92	0.00	879
2025-11-19	IRMD	86.64	0.93	0.00	874
2025-11-20	IRMD	87.64	0.93	1.57	875
2025-11-21	IRMD	88.52	0.96	1.00	884
2025-11-24	IRMD	90.31	0.96	0.17	884
2025-11-25	IRMD	91.99	0.91	0.17	649
2025-11-26	IRMD	92.9	0.91	0.00	651
2025-12-01	IRMD	92.42	0.79	0.00	705
2025-12-02	IRMD	92.26	0.79	1.50	705
2025-12-03	IRMD	93.17	0.79	0.00	709
2025-12-04	IRMD	93.95	0.79	0.00	712
2025-12-05	IRMD	94.39	0.79	0.30	714
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	IRMD	86.07	6.8	-	1.83
2025-11-11	IRMD	84.64	6.8	-	1.86
2025-11-12	IRMD	86.61	6.8	-	1.86
2025-11-13	IRMD	84.40	6.8	-	1.86
2025-11-14	IRMD	84.59	9.1	-	1.86
2025-11-17	IRMD	85.42	9.1	-	1.86
2025-11-18	IRMD	86.15	9.1	-	1.86
2025-11-19	IRMD	86.59	9.1	-	1.86
2025-11-20	IRMD	87.38	9.1	-	1.86
2025-11-21	IRMD	89.54	9.1	-	1.86
2025-11-24	IRMD	90.24	9.1	-	1.86
2025-11-25	IRMD	92.23	9.1	-	1.86
2025-11-26	IRMD	92.79	9.1	-	1.86
2025-12-01	IRMD	92.47	9.1	-	1.86
2025-12-02	IRMD	92.06	9.1	-	1.86
2025-12-03	IRMD	93.18	9.1	-	1.86
2025-12-04	IRMD	94.20	9.1	-	1.86
2025-12-05	IRMD	94.57	9.1	-	1.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	IRMD	-0.87	-0.78	1.99
2025-11-11	IRMD	-0.88	-0.78	1.99
2025-11-12	IRMD	-1.20	-0.78	2.48
2025-11-13	IRMD	-1.20	-0.78	2.48
2025-11-14	IRMD	-1.20	-0.78	2.48
2025-11-17	IRMD	-1.21	-1.59	2.47
2025-11-18	IRMD	-1.21	-1.59	2.47
2025-11-19	IRMD	-1.32	-1.59	2.47
2025-11-20	IRMD	-1.32	-1.59	2.47
2025-11-21	IRMD	-1.38	-1.59	2.47
2025-11-24	IRMD	-1.38	-0.36	2.47
2025-11-25	IRMD	-1.49	-0.36	2.47
2025-11-26	IRMD	-1.49	-0.36	3.33
2025-12-01	IRMD	-1.49	-0.34	3.33
2025-12-02	IRMD	-1.60	-0.34	3.33
2025-12-03	IRMD	-1.60	-0.34	3.33
2025-12-04	IRMD	-1.60	-0.34	3.33
2025-12-05	IRMD	-1.60	-0.34	3.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.43

Avg. EPS Est. Current Quarter

0.48

Avg. EPS Est. Next Quarter

0.46

Insider Transactions

-1.6

Institutional Transactions

-0.34

Beta

1.09

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

67.53

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

0.2

Max Drawdown 5-Year %

-49.4

Target Price

P/E

57.29

Forward P/E

44.61

PEG

5.37

P/S

14.94

P/B

12.23

P/Free Cash Flow

81.56

EPS

1.65

Average EPS Est. Cur. Y

1.86

EPS Next Y. (Est.)

2.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

26.31

Relative Volume

0.69

Return on Equity vs Sector %

-5.4

Return on Equity vs Industry %

3.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

iRadimed Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 160

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

stock quote shares IRMD – Iradimed Corp Stock Price stock today

news today IRMD – Iradimed Corp stock forecast ,stock prediction 2023 2024 2025

marketwatch IRMD – Iradimed Corp yahoo finance google finance

stock history IRMD – Iradimed Corp invest stock market

stock prices IRMD premarket after hours

ticker IRMD fair value insiders trading

IRIX – IRIDEX Corp.

Float Short %

2.39

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.94

Target Price

Analyst Recom

Performance Q

-31.86

Relative Volume

0.43

Beta

0.56

Ticker: IRIX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	IRIX	1.075	0.01	0.00	183
2025-11-11	IRIX	1.1705	0.01	0.00	191
2025-11-12	IRIX	0.9579	0.01	0.20	197
2025-11-13	IRIX	0.8851	0.01	0.00	204
2025-11-14	IRIX	0.975	0.01	0.00	207
2025-11-17	IRIX	0.9319	0.01	0.00	208
2025-11-18	IRIX	0.9384	0.01	0.00	216
2025-11-19	IRIX	0.9515	0.01	0.33	219
2025-11-20	IRIX	0.9401	0.01	0.00	222
2025-11-21	IRIX	0.94	0.01	0.00	222
2025-11-24	IRIX	0.91	0.01	0.00	222
2025-11-25	IRIX	0.9115	0.01	0.00	222
2025-11-26	IRIX	0.9532	0.01	0.00	222
2025-12-01	IRIX	0.9301	0.00	0.00	162
2025-12-02	IRIX	0.9121	0.00	0.00	162
2025-12-03	IRIX	0.94	0.00	0.00	162
2025-12-04	IRIX	0.9355	0.00	0.00	162
2025-12-05	IRIX	0.9403	0.00	0.00	163
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	IRIX	1.10	-	-	-
2025-11-11	IRIX	1.19	-	-	-
2025-11-12	IRIX	0.96	-	-	-
2025-11-13	IRIX	0.88	-	-	-
2025-11-14	IRIX	0.98	-	-	-
2025-11-17	IRIX	0.93	-	-	-
2025-11-18	IRIX	0.94	-	-	-
2025-11-19	IRIX	0.95	-	-	-
2025-11-20	IRIX	0.95	-	-	-
2025-11-21	IRIX	0.94	-	-	-
2025-11-24	IRIX	0.91	-	-	-
2025-11-25	IRIX	0.92	-	-	-
2025-11-26	IRIX	0.96	-	-	-
2025-12-01	IRIX	0.93	-	-	-
2025-12-02	IRIX	0.92	-	-	-
2025-12-03	IRIX	0.95	-	-	-
2025-12-04	IRIX	0.93	-	-	-
2025-12-05	IRIX	0.94	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	IRIX	2.18	-3.14	2.25
2025-11-11	IRIX	2.18	-3.14	2.25
2025-11-12	IRIX	2.18	-3.14	2.33
2025-11-13	IRIX	2.18	-3.14	2.33
2025-11-14	IRIX	2.15	-3.14	2.30
2025-11-17	IRIX	2.10	-0.79	2.28
2025-11-18	IRIX	3.21	-0.79	2.28
2025-11-19	IRIX	3.25	-0.79	2.28
2025-11-20	IRIX	3.27	-0.79	2.28
2025-11-21	IRIX	3.39	-0.79	2.28
2025-11-24	IRIX	3.39	1.75	2.29
2025-11-25	IRIX	3.34	1.75	2.29
2025-11-26	IRIX	3.34	1.75	2.39
2025-12-01	IRIX	3.32	1.77	2.39
2025-12-02	IRIX	3.32	1.77	2.39
2025-12-03	IRIX	3.32	1.77	2.39
2025-12-04	IRIX	3.35	1.77	2.39
2025-12-05	IRIX	3.35	1.77	2.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

Insider Transactions

3.35

Institutional Transactions

1.77

Beta

0.56

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.3

Max Drawdown 5-Year %

-91.6

Target Price

P/E

Forward P/E

PEG

P/S

0.32

P/B

P/Free Cash Flow

EPS

-0.3

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.04

Relative Volume

0.43

Return on Equity vs Sector %

-135.6

Return on Equity vs Industry %

-126.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

IRIDEX Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 93

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

stock quote shares IRIX – IRIDEX Corp. Stock Price stock today

news today IRIX – IRIDEX Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch IRIX – IRIDEX Corp. yahoo finance google finance

stock history IRIX – IRIDEX Corp. invest stock market

stock prices IRIX premarket after hours

ticker IRIX fair value insiders trading

No more stocks to show

XAIR – Beyond Air Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: XAIR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

OPGN – Opgen Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: OPGN

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y